Literature DB >> 21971711

Portuguese version of the bath indexes for ankylosing spondylitis patients: a cross-cultural adaptation and validation.

F M Pimentel-Santos1, T Pinto, H Santos, A Barcelos, I Cunha, J C Branco, P L Ferreira.   

Abstract

The Bath Ankylosing Spondylitis Activity Index (BASDAI), Functional Index (BASFI), Metrology Index (BASMI), and Global Score (BASG) are commonly used to assess patients with ankylosing spondylitis (AS). The aim of this study was to cross-culturally adapt and validate these indexes into the Portuguese language. Seventy-eight patients were included in the study. After forward and backward translations, the questionnaires were administered and tested for internal consistency, test-retest reliability, face validity, content validity, and construct validity. The outcome measures HAQ, EQ-5D, and SF-36 were also implemented. Metrological parameters (BASMI components) and chest expansion were evaluated. Correlation coefficients for test-retest were 0.875, 0.937, 0.831, and 0.961 for BASDAI, BASFI, BASMI, and BASG, respectively. Internal consistency coefficients were between 0.747 and 0.953. The adapted and translated questionnaires demonstrated an acceptable comprehensibility by a panel of patients, and face validity was assured by the cognitive debriefing performed. Content validity was assured by comparing the scores obtained by the questionnaires when age and gender, age of symptoms onset, and disease duration were considered. Construct validity was assured by significant correlations established between the Bath scores and generic health status HAQ, EQ-5D and SF-36, morning stiffness duration, chest expansion, and physician disease activity assessment. The Portuguese version of the BASDAI, BASFI, BASG, and BASMI showed adequate reliability and validity in patients with AS. The measurement properties were comparable to versions in other languages, indicating that the indexes can be used for evaluation of Portuguese-speaking AS patients.

Entities:  

Mesh:

Year:  2011        PMID: 21971711     DOI: 10.1007/s10067-011-1864-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  19 in total

1.  [Development of the Portuguese version of MOS SF-36. Part II --Validation tests].

Authors:  P L Ferreira
Journal:  Acta Med Port       Date:  2000 May-Jun

2.  Quality criteria were proposed for measurement properties of health status questionnaires.

Authors:  Caroline B Terwee; Sandra D M Bot; Michael R de Boer; Daniëlle A W M van der Windt; Dirk L Knol; Joost Dekker; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2006-08-24       Impact factor: 6.437

3.  The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

Authors:  S D Jones; A Steiner; S L Garrett; A Calin
Journal:  Br J Rheumatol       Date:  1996-01

Review 4.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  [Measuring agreement between 2 observers: a quantitative case].

Authors:  J Fermanian
Journal:  Rev Epidemiol Sante Publique       Date:  1984       Impact factor: 1.019

7.  Evaluation of the Finnish versions of the functional indices BASFI and DFI in spondylarthropathy.

Authors:  S Heikkilä; J V Viitanen; H Kautianen; M Kauppi
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

8.  ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health.

Authors:  A Boonen; J Braun; I E van der Horst Bruinsma; F Huang; W Maksymowych; N Kostanjsek; A Cieza; G Stucki; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

9.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

10.  Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients.

Authors:  Zhiming Lin; Jieruo Gu; Peigen He; Jiesheng Gao; Xiaoxia Zuo; Zhizhong Ye; Fengmin Shao; Feng Zhan; Jinying Lin; Li Li; Yanlin Wei; Manlong Xu; Zetao Liao; Qu Lin
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

View more
  4 in total

1.  Validity and reliability of the Short Form 36 Health Surveys (SF-36) among patients with spondyloarthritis in Singapore.

Authors:  Yu Heng Kwan; Warren Weng Seng Fong; Nai Lee Lui; Si Ting Yong; Yin Bun Cheung; Rahul Malhotra; Truls Østbye; Julian Thumboo
Journal:  Rheumatol Int       Date:  2016-09-23       Impact factor: 2.631

Review 2.  The health-related quality of life of ankylosing spondylitis patients assessed by SF-36: a systematic review and meta-analysis.

Authors:  Xiao Yang; Dazhi Fan; Qing Xia; Mengmeng Wang; Xu Zhang; Xiaona Li; Guoqi Cai; Li Wang; Lihong Xin; Shengqian Xu; Faming Pan
Journal:  Qual Life Res       Date:  2016-06-20       Impact factor: 4.147

3.  Prevalence of Temporomandibular Joint Disorders in Patients with Ankylosing Spondylitis: A Cross-Sectional Study.

Authors:  Rebeca Cecília Souza; Emerson Tavares de Sousa; David Sousa; Marcelo Sales; Rudyard Dos Santos Oliveira; Maria Helena Mariano; Eliézer Rushansky; Ana Cláudia Amorim Gomes; Emanuel Silva
Journal:  Clin Cosmet Investig Dent       Date:  2021-11-11

4.  Validation of Portuguese-translated computer touch-screen questionnaires in patients with rheumatoid arthritis and spondyloarthritis, compared with paper formats.

Authors:  Luís Cunha-Miranda; Helena Santos; Cláudia Miguel; Cândida Silva; Filipe Barcelos; Joana Borges; Ricardo Trinca; Vera Vicente; Tiago Silva
Journal:  Rheumatol Int       Date:  2015-09-07       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.